AKT pathway is one of the upstream regulators of PHF19 expression [34, 43] and PHF19 promotes AKT pathway signaling [45] and CDK1 seems to be one of the downstream target of PHF19 activity in MM (See below). Here, AKT1 is linked to Miyoshi myopathy.